• Study of Dasatinib and Quercetin combination for treating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark Finland France Germany Hungary +3

  • Study on Nemvaleukin Alfa and Pembrolizumab for Patients with Advanced Skin or Mucosal Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain

  • Study on Lutetium (177Lu) Zadavotide Guraxetan for Patients with Recurrent Grade 3 and Grade 4 Glioma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Study of cabozantinib with atezolizumab compared to sorafenib in untreated patients with advanced liver cancer (hepatocellular carcinoma)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Hungary Romania Spain

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium France Germany

  • Study on Dalbavancin and Rifampicin for Treating Prosthetic Joint Infections in Patients with Hip, Knee, and Shoulder Replacements

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of Durvalumab and Tremelimumab for Patients with Colorectal and Endometrial Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Finland France Germany Italy +3

powered by